Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suwicha Limvorasak

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|November 21, 2009
Kinase inhibitors in prostate cancerSuwicha Limvorasak, Edwin M Posadas
Expert Opinion on Pharmacotherapy|December 4, 2009
Pazopanib: therapeutic developmentsSuwicha Limvorasak, Edwin M Posadas
Oncology (Williston Park, N.Y.)|September 17, 2016
Third-Line Treatment Options for Kidney CancerEdwin M Posadas, Suwicha Limvorasak, Robert A Figlin
Nature Reviews. Nephrology|July 11, 2017
Targeted therapies for renal cell carcinomaEdwin M Posadas, Suwicha Limvorasak, Robert A Figlin
Expert Opinion on Pharmacotherapy|August 30, 2013
Targeting angiogenesis in renal cell carcinomaEdwin M Posadas, Suwicha Limvorasak, Shaleekha Sharma, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 6, 2022
Adapting investigational drug services during a pandemic: Recommendations for future preparedness from the Hematology/Oncology Pharmacy Association Investigational Drug Services Special Interest GroupHeidi D Finnes, Berrie Child, Sean DeFrates, et al.
Journal of Clinical Bioinformatics|May 24, 2011
Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology databaseMosmi Surati, Matthew Robinson, Suvobroto Nandi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Anti-Cancer Agents in Medicinal Chemistry|November 21, 2009
Kinase inhibitors in prostate cancerSuwicha Limvorasak, Edwin M Posadas
Expert Opinion on Pharmacotherapy|December 4, 2009
Pazopanib: therapeutic developmentsSuwicha Limvorasak, Edwin M Posadas
Oncology (Williston Park, N.Y.)|September 17, 2016
Third-Line Treatment Options for Kidney CancerEdwin M Posadas, Suwicha Limvorasak, Robert A Figlin
Nature Reviews. Nephrology|July 11, 2017
Targeted therapies for renal cell carcinomaEdwin M Posadas, Suwicha Limvorasak, Robert A Figlin
Expert Opinion on Pharmacotherapy|August 30, 2013
Targeting angiogenesis in renal cell carcinomaEdwin M Posadas, Suwicha Limvorasak, Shaleekha Sharma, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 6, 2022
Adapting investigational drug services during a pandemic: Recommendations for future preparedness from the Hematology/Oncology Pharmacy Association Investigational Drug Services Special Interest GroupHeidi D Finnes, Berrie Child, Sean DeFrates, et al.
Journal of Clinical Bioinformatics|May 24, 2011
Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology databaseMosmi Surati, Matthew Robinson, Suvobroto Nandi, et al.
Pageof 1